Translating Discovery into Better Patient Care Streamlining communication and collaboration for the advancement of health solutions and effective patient-care. With the mandate to connect patients and the most advanced therapeutic solutions, our office of Clinical Research provides first-in-man clinical trials, hospital exemptions, and compassionate off-label use.
Ongoing clinical trials
Days - IRB authorization turnaround time
Annual IRB committee meetings
Together we are tackling some of the greatest challenges in healthcare.
Learn more about our impact and discoveries in development.
More Highlights >>
Pancreatic cancer adenocarcinoma (PDAC) is a dire disease with no good treatment and a five-year survival of only 5%. While most PDAC …
The liver has a remarkable ability to renew itself in a process called regeneration- regrowth of liver tissue following partial resection or …
Fragile X syndrome (FXS), the most common form of inherited intellectual disability, is caused by a developmentally regulated silencing of the FMR1 …
Breast cancer is the most common type of cancer among women, with highest death cases, and when the disease is metastatic, it …